Mirtazapine D3

Modify Date: 2024-01-02 12:48:42

Mirtazapine D3 Structure
Mirtazapine D3 structure
Common Name Mirtazapine D3
CAS Number 1216678-68-0 Molecular Weight 268.37100
Density N/A Boiling Point N/A
Molecular Formula C17H16D3N3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Mirtazapine D3


Mirtazapine D3 (Org3770 D3; 6-Azamianserin D3) is a deuterium labeled Mirtazapine. Mirtazapine is a 5-HT receptor inhibitor. Mirtazapine is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent by blocking 5-HT2 and 5-HT3 receptors[1].

 Names

Name Mirtazapine-d3

 Mirtazapine D3 Biological Activity

Description Mirtazapine D3 (Org3770 D3; 6-Azamianserin D3) is a deuterium labeled Mirtazapine. Mirtazapine is a 5-HT receptor inhibitor. Mirtazapine is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent by blocking 5-HT2 and 5-HT3 receptors[1].
Related Catalog
Target

5-HT2 Receptor

5-HT3 Receptor

In Vivo Mirtazapine (intraperitoneal injection; 10–50 mg/Kg; 14 days) treatment normalizes heart rate, breath rate, anxiety levels and eliminates the hopping behavior observed in MeCP2-null mice, leading to improved phenotypic score[2]. Animal Model: MeCP2 null mice[2] Dosage: 10-50 mg/Kg Administration: Intraperitoneal injection; 10-50 mg/Kg; 14 days Result: Restored the thickness of MeCP2-null mice somatosensory cortex, especially of layers II-III and VI.
References

[1]. Anttila, S.A. and E.V. Leinonen, A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev, 2001. 7(3): p. 249-64.

[2]. Kooyman AR, et al. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells.Neuropharmacology. 1994 Mar-Apr;33(3-4):501-7.

 Chemical & Physical Properties

Molecular Formula C17H16D3N3
Molecular Weight 268.37100
Exact Mass 268.17700
PSA 19.37000
LogP 2.48180